| Product Code: ETC5259151 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Malta import of colistin in 2024 continued to be dominated by key exporters such as China, Greece, USA, Japan, and Bulgaria. The Herfindahl-Hirschman Index (HHI) indicated a high level of market concentration, suggesting limited competitive dynamics. Despite a modest compound annual growth rate (CAGR) of 0.28% from 2020 to 2024, the remarkable growth rate of 152.1% in 2024 indicates a notable surge in demand for colistin within the Maltese market, potentially driven by various factors such as healthcare needs or regulatory changes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Colistin Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Colistin Market - Industry Life Cycle |
3.4 Malta Colistin Market - Porter's Five Forces |
3.5 Malta Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Malta Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Malta Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multidrug-resistant infections |
4.2.2 Growing awareness about the effectiveness of colistin in treating certain bacterial infections |
4.2.3 Rise in hospital-acquired infections due to the aging population and increased healthcare facilities |
4.3 Market Restraints |
4.3.1 Concerns over colistin resistance and associated risks |
4.3.2 Stringent regulations on the use of colistin in livestock and agriculture |
4.3.3 Availability of alternative antibiotics and treatment options |
5 Malta Colistin Market Trends |
6 Malta Colistin Market Segmentations |
6.1 Malta Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Colistin Market Revenues & Volume, By API, 2021-2031F |
6.1.3 Malta Colistin Market Revenues & Volume, By Premix, 2021-2031F |
6.1.4 Malta Colistin Market Revenues & Volume, By Others, 2021-2031F |
6.2 Malta Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Malta Colistin Market Revenues & Volume, By Pig, 2021-2031F |
6.2.3 Malta Colistin Market Revenues & Volume, By Chicken, 2021-2031F |
6.2.4 Malta Colistin Market Revenues & Volume, By Other, 2021-2031F |
7 Malta Colistin Market Import-Export Trade Statistics |
7.1 Malta Colistin Market Export to Major Countries |
7.2 Malta Colistin Market Imports from Major Countries |
8 Malta Colistin Market Key Performance Indicators |
8.1 Number of reported multidrug-resistant bacterial infections |
8.2 Adoption rate of colistin in hospitals and healthcare facilities |
8.3 Research and development investments in colistin alternatives |
8.4 Number of regulatory approvals for colistin use in different sectors |
8.5 Patient outcomes and success rates with colistin treatment |
9 Malta Colistin Market - Opportunity Assessment |
9.1 Malta Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Malta Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Malta Colistin Market - Competitive Landscape |
10.1 Malta Colistin Market Revenue Share, By Companies, 2024 |
10.2 Malta Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |